ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Schrodinger Inc

Schrodinger Inc (SDGR)

18.73
-0.22
( -1.16% )
Updated: 12:39:06

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
18.73
Bid
18.73
Ask
18.75
Volume
301,808
18.69 Day's Range 19.00
18.69 52 Week Range 59.24
Market Cap
Previous Close
18.95
Open
18.83
Last Trade
1
@
18.74
Last Trade Time
12:39:22
Financial Volume
$ 5,680,996
VWAP
18.8232
Average Volume (3m)
717,551
Shares Outstanding
72,679,390
Dividend Yield
-
PE Ratio
33.52
Earnings Per Share (EPS)
0.56
Revenue
216.67M
Net Profit
40.72M

About Schrodinger Inc

Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the... Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. Schrodinger generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
1970
Schrodinger Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker SDGR. The last closing price for Schrodinger was $18.95. Over the last year, Schrodinger shares have traded in a share price range of $ 18.69 to $ 59.24.

Schrodinger currently has 72,679,390 shares outstanding. The market capitalization of Schrodinger is $1.36 billion. Schrodinger has a price to earnings ratio (PE ratio) of 33.52.

SDGR Latest News

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Schrödinger, Inc. (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, today reported that on June 11, 2024, the company...

Schrödinger to Present at Jefferies Global Healthcare Conference

Schrödinger (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, today announced that management will participate in a...

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Schrödinger, Inc. (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, today reported that on May 16, 2024, the company...

Schrödinger Reports First Quarter 2024 Financial Results

First Quarter Total Revenue of $36.6 Million, Software Revenue of $33.4 Million Announces FDA Clearance of Investigational New Drug Application for SGR-3515, a Novel Wee1/Myt1 Inhibitor SGR-1505...

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Schrödinger, Inc. (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, today reported that on April 15, 2024, the company...

Schrödinger to Announce First Quarter 2024 Financial Results on May 1

Schrödinger (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, will report its first quarter 2024 financial results on...

Schrödinger Highlights Discovery of SGR-1505, Clinical-Stage MALT1 Inhibitor, at American Chemical Society National Meeting

Schrödinger, Inc. (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, today presented the discovery of SGR-1505, its...

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Schrödinger, Inc. (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, today reported that on March 15, 2024, the company...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-2.14-10.253953042620.8721.0718.6974120519.59085075CS
4-3.27-14.86363636362223.4718.6965136521.26671318CS
12-8.37-30.885608856127.129.1518.6971755123.49646229CS
26-16.02-46.100719424534.753818.6980178326.37586894CS
52-29.26-60.971035632447.9959.2418.6988478032.28521757CS
156-55.28-74.692609106974.0179.7515.8578118234.0929464CS
260-11.72-38.489326765230.4511715.8589659246.40612675CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AREBAmerican Rebel Holdings Inc
$ 0.8037
(167.01%)
273.97M
SHCRSharecare Inc
$ 1.365
(76.27%)
32.68M
NXLNexalin Technologies Inc
$ 1.84
(67.27%)
39.9M
SPECSpectaire Holdings Inc
$ 0.537683
(58.14%)
58.64M
MINMMinim Inc
$ 3.885
(35.84%)
41.31M
KAVLKaival Brands Innovations Group Inc
$ 1.475
(-48.61%)
3.24M
PBMPsyence Biomedical Ltd
$ 0.3931
(-34.48%)
2.17M
JSPRWJasper Therapeutics Inc
$ 0.1618
(-26.45%)
6.25k
RELIReliance Global Group Inc
$ 0.4631
(-23.32%)
7.23M
SMXSMX Security Matters Public Company
$ 0.129
(-19.78%)
10.15M
NVDANVIDIA Corporation
$ 129.3399
(-1.10%)
278.08M
AREBAmerican Rebel Holdings Inc
$ 0.8062
(167.84%)
273.98M
CRKNCrown Electrokinetics Corporation
$ 0.0414
(-17.20%)
131.44M
ASTIAscent Solar Technologies Inc
$ 0.1146
(6.21%)
110.61M
NKLANikola Corporation
$ 0.3684
(11.77%)
110.52M

SDGR Discussion

View Posts
scotsand scotsand 9 months ago
This needs to turn around soon. So oversold.
👍️0
scotsand scotsand 1 year ago
Beast mode
👍️0
scotsand scotsand 1 year ago
Love this ticker
👍️0
scotsand scotsand 1 year ago
Up 20%. Guess was right… adding.
👍️0
scotsand scotsand 2 years ago
Now is the time to add.
👍️0
Porterhouse10 Porterhouse10 3 years ago
Cathy Woods adding
👍️0
nowwhat2 nowwhat2 3 years ago



👍️0
adtime adtime 3 years ago
This was a fun move hope someone followed ;) 8% at peak today ftw
👍️0
adtime adtime 3 years ago
Nice set up if gets into 60
👍️0
ernie44 ernie44 3 years ago
M and A -------------------------
merger looming---microsoft
👍️0
Bucketh3ad Bucketh3ad 4 years ago
Smh
👍️0
chrispy2468 chrispy2468 4 years ago
Any insight to this upward move after hours?
👍️0
canadiansalmongal canadiansalmongal 4 years ago
Very Solid company with HUGE money supporting it...Long term Hold this is a golden ticket going forward $100 PT this time next year!
👍️0
chrispy2468 chrispy2468 4 years ago
Little action AH
👍️0
RodgeDodger RodgeDodger 4 years ago
Still running
👍️0
crudeoil24 crudeoil24 4 years ago
I am not holding shares. It may run some more, plus not everyone is familiar with Citron the beast! > LOL.
👍️0
realfast95 realfast95 4 years ago
yea he exaggerates his long ideas. TLRY,RVLV come to mind
👍️0
crudeoil24 crudeoil24 4 years ago
Citron > will they be shorting tomorrow? Playing off the TSLA hype!

👍️0
chrispy2468 chrispy2468 4 years ago
Bullish
👍️0
TheFinalCD TheFinalCD 4 years ago
https://citronresearch.com/schrodinger-sdgr-taking-drug-discovery-to-the-space-age/
👍️0
realfast95 realfast95 4 years ago
Citron pump

https://twitter.com/CitronResearch/status/1230538195726503942

Citron Research
@CitronResearch
$SDGR the most important IPO past 5 years. Taking drug discovery to "space age". The parallels to an early stage $TSLA are too obvious to ignore. Don't take Citron's word, look at the majority shareholders AI molecular simulation is real disruption. TGT- $80

👍️0
RodgeDodger RodgeDodger 4 years ago
Still running
👍️0
crudeoil24 crudeoil24 4 years ago
Schrodinger Shares Surge 55% After IPO Priced Above High End of Range >SDGR
12:39 pm ET February 6, 2020 (Dow Jones) Print
By Colin Kellaher

Shares of Schrodinger Inc. (SDGR) jumped more than 55% in their trading debut Thursday after the drug discovery software company's upsized initial public offering of 11.9 million shares was priced at $17 apiece, above the expected range.

Schrodinger shares recently were trading at $26.54, up about 56%, after opening at $26.

The New York company, whose investors include D.E. Shaw and the Bill & Melinda Gates Foundation, previously said it planned to sell 10 million shares at $14 to $16 each in the IPO.

The company has granted the underwriters an option to buy up to 1.78 million additional shares.
👍️0
crudeoil24 crudeoil24 4 years ago
Schrodinger Inc is headquartered in New York City, New York, United States and is a software publisher. The company's key areas of interest are Computational Chemistry Software, Molecular Modeling, Dockings, Homology Modeling, Cheminformatics, Pharmacophore Modeling, Qsars, Computational Biology, Computer Chemistry, Quantum Chemistry, Software For Chemistry. The company was founded in 1995.

👍️0

Your Recent History

Delayed Upgrade Clock